Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,441,936
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
21,874,386
-
Shares change
-
+700,723
-
Total reported value, excl. options
-
$110,684,000
-
Value change
-
+$2,844,383
-
Number of buys
-
22
-
Number of sells
-
17
-
Price
-
$5.06
Institutional Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q2 2022
As of 30 Jun 2022 Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) had 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,874,386 shares of stock of the company.
Largest 10 holders included FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Velan Capital Investment Management LP, Saba Capital Management, L.P., Triatomic Management LP, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This table shows 33 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.